Screener
Amgen AMGN Common Stock Par Value Per Share
Common Stock Par Value Per Share at other companies
Other financials
Where this comes from
Reported directly by Amgen in its filing.
Tagged under the XBRL concept us-gaap:CommonStockParOrStatedValuePerShare.
The source filing: Amgen’s 10-Q, filed August 5, 2026.
- Filed
- Aug 4, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000318154-26-000126
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Other noncurrent liabilities | 2,445 | 2,378 |
| Contingencies and commitments (see Note 13) | ||
| Stockholders’ equity: | ||
| Common stock and additional paid-in capital; $0.0001 par value; 2,750.0 shares authorized; outstanding—540.6 shares in 2026 and 538.8 shares in 2025 | 34,082 | 34,023 |
| Accumulated deficit | (22,275) | (25,107) |
| Accumulated other comprehensive loss | (119) | (258) |
| Total stockholders’ equity | 11,688 | 8,658 |
| Total liabilities and stockholders’ equity | $95,639 | $90,586 |
Item 1. FINANCIAL STATEMENTS
FAQ
- What is Amgen's common stock par value per share?
- Amgen (AMGN) reported common stock par value per share of $0.00 in Q2 2026.
- How has Amgen's common stock par value per share changed year-over-year?
- Amgen's common stock par value per share decreased by 0.0% year-over-year, from $0.00 to $0.00.
- What is the long-term trend for Amgen's common stock par value per share?
- Over 5 years (2020 to 2025), Amgen's common stock par value per share has grown at a 0.0% compound annual growth rate (CAGR), from $0.00 to $0.00.
- What does common stock par value per share mean?
- The par value of common stock is the arbitrary legal value assigned to each share of common stock at the time of issuance. It is a legacy accounting requirement that has little impact on the actual market value or trading price of the shares.
Ask your AI about Amgen's common stock par value per share.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude